Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT04483362




Registration number
NCT04483362
Ethics application status
Date submitted
14/07/2020
Date registered
23/07/2020
Date last updated
3/06/2022

Titles & IDs
Public title
CanMove: A Physical Activity Program for Children With Cancer
Scientific title
CanMove: The Feasibility of Implementing a Physical Activity Intervention for Children Undergoing Acute Cancer Treatment
Secondary ID [1] 0 0
MurdochCRI
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Pediatric Cancer 0 0
Condition category
Condition code

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
BEHAVIORAL - Complex physical activity intervention

Experimental: Physical Activity - Behavioural change techniques to promote physical activity


BEHAVIORAL: Complex physical activity intervention
Structured weekly sessions with a Physiotherapist over an 8 week period, including:

* Evaluation of current levels of physical activity and physical function - including discussion of results
* Education regarding the importance of physical activity
* Supervised physical activity session with a physiotherapist
* Structured weekly sessions applying behavioural change techniques which aim to increase participation in physical activity. Sessions include: provision of activity monitor (Fitbit Inspire), goal setting, monitoring, collaborative problem solving and action plan implementation. Intervention includes additional time allowance of 1 hour per week to assist in implementing action plan items
Intervention code [1] 0 0
BEHAVIORAL
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Demand for the intervention
Timepoint [1] 0 0
Through completion of recruitment, estimated as 9 months
Primary outcome [2] 0 0
Acceptability of the intervention according to participants
Timepoint [2] 0 0
After completion of the intervention (on average 8 weeks)
Primary outcome [3] 0 0
Acceptability of the intervention according to staff
Timepoint [3] 0 0
Through study completion, estimated as 1 year
Primary outcome [4] 0 0
Implementation of the intervention: adherence to wearing Fitbit
Timepoint [4] 0 0
Post intervention (on average 8 weeks)
Primary outcome [5] 0 0
Implementation of the intervention: attendance to intervention sessions
Timepoint [5] 0 0
Post intervention (on average 8 weeks)
Primary outcome [6] 0 0
Implementation of the intervention: ability for participants to attain their steps per day goal
Timepoint [6] 0 0
Post intervention (on average 8 weeks)
Primary outcome [7] 0 0
Practicality of the intervention: adverse events
Timepoint [7] 0 0
Post the participant's final trial visit (on average 12 weeks)
Primary outcome [8] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: Actigraph steps per day
Timepoint [8] 0 0
Post intervention (on average 8 weeks)
Primary outcome [9] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: Fitbit steps per day
Timepoint [9] 0 0
Post intervention (on average 8 weeks)
Primary outcome [10] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: Actigraph distance travelled per day
Timepoint [10] 0 0
Post intervention (on average 8 weeks)
Primary outcome [11] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: Fitbit distance travelled per day
Timepoint [11] 0 0
Post intervention (on average 8 weeks)
Primary outcome [12] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: Actigraph physical activity intensity
Timepoint [12] 0 0
Post intervention (on average 8 weeks)
Primary outcome [13] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: Fitbit physical activity intensity
Timepoint [13] 0 0
Post intervention (on average 8 weeks)
Primary outcome [14] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: sedentary bouts
Timepoint [14] 0 0
Post intervention (on average 8 weeks)
Primary outcome [15] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: body position
Timepoint [15] 0 0
Post intervention (on average 8 weeks)
Primary outcome [16] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: active hours
Timepoint [16] 0 0
Post intervention (on average 8 weeks)
Primary outcome [17] 0 0
Limited efficiency testing assessing changes in physical activity between pre and post intervention: active minutes
Timepoint [17] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [1] 0 0
Limited efficiency testing assessing changes in physical function from pre to post intervention: Movement ABC
Timepoint [1] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [2] 0 0
Limited efficiency testing assessing changes in physical function from pre to post intervention: 6 Minute Walk Test
Timepoint [2] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [3] 0 0
Limited efficiency testing assessing changes in physical function from pre to post intervention: Timed Up and Go
Timepoint [3] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [4] 0 0
Limited efficiency testing assessing changes in physical function from pre to post intervention: Timed Up and Down Stairs
Timepoint [4] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [5] 0 0
Limited efficiency testing assessing changes in physical function from pre to post intervention: Time to Rise from the Floor
Timepoint [5] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [6] 0 0
Limited efficiency testing assessing changes in physical function from pre to post intervention: Time to Rise from the Floor
Timepoint [6] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [7] 0 0
Limited efficiency testing assessing changes in Health-related Quality of Life from pre to post intervention: self-reported Pediatric Quality of Life Inventory-core generic module
Timepoint [7] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [8] 0 0
Limited efficiency testing assessing changes in Health-related Quality of Life from pre to post intervention: proxy-reported Pediatric Quality of Life Inventory-core generic module
Timepoint [8] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [9] 0 0
Feasibility: Limited efficiency testing assessing changes in Health-related Quality of Life from pre to post intervention: self-reported PedsQL-cancer module
Timepoint [9] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [10] 0 0
Feasibility: Limited efficiency testing assessing changes in Health-related Quality of Life from pre to post intervention: proxy-reported PedsQL-cancer module
Timepoint [10] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [11] 0 0
Categorisation and frequency of reported barriers to physical activity
Timepoint [11] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [12] 0 0
Categorisation and frequency of action plan strategies
Timepoint [12] 0 0
Post intervention (on average 8 weeks)
Secondary outcome [13] 0 0
Utility of physical function assessment tools, measured by completeness of assessment data for physical function
Timepoint [13] 0 0
Post completion of follow up assessment (on average 10 weeks)
Secondary outcome [14] 0 0
Utility of physical activity assessment tools, measured by completeness of assessment data for physical activity
Timepoint [14] 0 0
Post completion of follow up assessment (on average 10 weeks)

Eligibility
Key inclusion criteria
* Is between the ages of 5-17 years at the time of consent
* Diagnosed (or relapsed) with cancer >4 weeks and <6 months at time of consent
* Currently receiving cancer treatment at the Royal Children's Hospital
* Has been an in-patient for >7 consecutive days at the time of consent
* Provide a signed and dated informed consent form and/or has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf
Minimum age
5 Years
Maximum age
17 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Deemed by the treating medical team as unsafe to participate
* Child/adolescent unable to mobilise independent of clinical staff assistance, as classified by the research team at the time of consent (use of a gait aid or assistance from a primary carer/support person is accepted). For example, if a child/adolescent requires assistance from nursing staff or physiotherapist in order to walk, they will be excluded.
* Child/adolescent unable to follow simple instructions
* Suitable support person (18 years and over) not available to participate in continuous monitoring of daily steps in tandem with the child/adolescent
* No suitable access to a device to sync with a Fitbit
* Inability or unwillingness of participant or legally acceptable representative to give written informed consent.

Study design
Purpose of the study
Other
Allocation to intervention
Not applicable
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
9/11/2020
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
3/09/2021
Sample size
Target
Accrual to date
Final
21
Recruitment in Australia
Recruitment state(s)
Victor
Recruitment hospital [1] 0 0
Royal Children's Hospital - Parkville
Recruitment postcode(s) [1] 0 0
3052 - Parkville

Funding & Sponsors
Primary sponsor type
Other
Name
Murdoch Childrens Research Institute
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
La Trobe University
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
This study will evaluate a physical activity intervention for children during acute cancer treatment. The intervention aims to encourage children to participate in increased levels of physical activity and reduce the amount of time they spend engaged in sedentary activities. This study also aims to evaluate different ways of assessing physical function in order to determine the best outcome measure to use for children during acute cancer treatment.
Trial website
https://clinicaltrials.gov/study/NCT04483362
Trial related presentations / publications
Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002.
Public notes

Contacts
Principal investigator
Name 0 0
Sarah L Grimshaw
Address 0 0
Murdoch Children's Research Institute
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT04483362